[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
#  @AnotherBio AnotherBioInvestor
AnotherBioInvestor posts on X about $prtc, $fgen, tang, $vigl the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
### Engagements: XXX [#](/creator/twitter::1364531118830219266/interactions)
- X Week XXXXXX +572%
- X Month XXXXXX +14%
- X Months XXXXXX +3,284%
- X Year XXXXXX +288%
### Mentions: XX [#](/creator/twitter::1364531118830219266/posts_active)
### Followers: XXXXX [#](/creator/twitter::1364531118830219266/followers)
- X Week XXXXX +5.40%
- X Month XXXXX +18%
- X Months XXXXX +107%
- X Year XXXXX +124%
### CreatorRank: XXXXXXXXX [#](/creator/twitter::1364531118830219266/influencer_rank)
### Social Influence [#](/creator/twitter::1364531118830219266/influence)
---
**Social category influence**
[finance](/list/finance) [stocks](/list/stocks) [cryptocurrencies](/list/cryptocurrencies) [countries](/list/countries)
**Social topic influence**
[$prtc](/topic/$prtc) #1, [$fgen](/topic/$fgen) #1, [tang](/topic/tang), [$vigl](/topic/$vigl), [$bpmc](/topic/$bpmc), [decent](/topic/decent), [reverse](/topic/reverse), [$bmy](/topic/$bmy), [holders](/topic/holders), [discount](/topic/discount)
**Top assets mentioned**
[Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Company (COMPANY)](/topic/$company) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Synthetify (SNY)](/topic/$sny) [Sanofi (SNY)](/topic/sanofi)
### Top Social Posts [#](/creator/twitter::1364531118830219266/posts)
---
Top posts by engagements in the last XX hours
"1) Here is a thread about a takeover offer that was rebutted. AFAIK terms have never leaked. Thread includes a rough valuation but some pieces are a bit outdated ($BMY had a severe setback with Cobenfy for example but still a massive shot on goal this year)"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945390254313320577) 2025-07-16 07:49:14 UTC 1105 followers, XXX engagements
"Ladies and gents since it is officially shitco season time to check what we can still gobble up from the dumpsters. May I present: $FGEN In short: - Trades at XX% of net cash after asset sale to AstraZeneca closes - runway into H2 XX - Phase X mCRPC data of its ADC + PET Imaging Agent coming up in H2 XX - "maybe theres a chance" revival of Roxadustat in US in H2 2025 hopefully with a partner - Lo and behold - Insider Buys Stock has a horrible history with lead asset Roxadustat failing in US (approved and reasonably successful marketed in China with Astrazeneca). Why is the stock cheap and /"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1943018179225137356) 2025-07-09 18:43:28 UTC 1117 followers, 3553 engagements
"$CRGX Did not own this as discount to net cash was very small (as deal shows). Think it's a short above X as always dont trust Tang to monetize assets in best interest for CVR holders"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1942541581342630128) 2025-07-08 11:09:38 UTC 1117 followers, 1809 engagements
"$VIGL HSR expired. Will take profits for remaining position just keeping a tracker for the CVR. Returned XXX% or XX annualized from my write-up. CVR implies X% PoS at 8.08$ with zero closing risk assumed. Not a challenging valuation at all but probably justified given the minefield of Trem2-fails"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945805263757365446) 2025-07-17 11:18:20 UTC 1117 followers, XXX engagements
"5) We have some pretty heavy catalysts in H2 2025 which can be pretty dramatic for a 25mln-US$-company. Please do not ask me on the science. It looks like a "might work"-thingy insiders are buying tons of cash lots of ways to wins - all I care about Another catalyst is of course closing the Astra sale and cash in amount of XXX times the market cap popping up on the balance sheet"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1943018190696542381) 2025-07-09 18:43:30 UTC 1117 followers, XXX engagements
"6) $VOR mooning hope $PRTC monetizes that stake valuation is incredibly high due to technical reasons (short interest low float newly issued shares not tradeable yet). Small impact (couple million $) but Ill take it"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945390265545502980) 2025-07-16 07:49:17 UTC 1117 followers, XXX engagements
"$PRTC Made a post already yday on strong words of CEO / Chair in annual letter but have to follow up on this after reading the transcript. This is the most shareholder-friendly language I have seen in a long time in biotech (if not ever this is biotech though so bar is low 🙃) and coming from a highly credible company - one that already actually did a buyback and tender offer. The fact that you can buy this basically unchanged from this conference call is somewhat mindblowing to me"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1917850434221363269) 2025-05-01 07:55:50 UTC 1117 followers, 3959 engagements
"4) Results of AGM. Shareholders made their frustration noted Chair only received XX% of votes. Interestingly Ms Mazumdar-Shaw is somehow still on the board while CEO and BoD Chair have stepped down Not important but. the hell"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945390260017365201) 2025-07-16 07:49:16 UTC 1107 followers, XXX engagements
"$PRTC looks like a ton is happening behind the scenes. BoD Chair and CEO have now been replaced. Both replacements are people with a very financy background which increases my conviction that $PRTC is in some stage of winddown or at least very severe consolidation. Have a lot of posts / threads all over the place will gather them right here. TLDR: Great r/r imo lots of ways to win lots of value people are saying all the right things. Now they need to walk the walk. Read the whole thing though you lazy asses"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945390252035858810) 2025-07-16 07:49:14 UTC 1117 followers, 5318 engagements
"7) ex-CEO of $PRTC now CEO of $PRTC s largest holding (Seaport) making a bunch of interesting statements about creating shareholder value being very important and what M&A premium platform companies (like Seaport) are commanding. Exit / IPO coming"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945390267730682113) 2025-07-16 07:49:18 UTC 1117 followers, XXX engagements
"$SRPT So they will probably do 1-2 bln in profits a year after everyone forgets about this and the stock sits at. 2.8bln $ Okay. (I know its more complicated than that but also.not really)"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945577991792124366) 2025-07-16 20:15:14 UTC 1117 followers, 7485 engagements
"$IGMS Everybody: Well that IP is probably worth at least something or biobucks. Kevin Tang: Sorry bro zero is all I can do"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945807538412286425) 2025-07-17 11:27:23 UTC 1117 followers, XXX engagements
"$BPMC lol I think thats a new one for me. You can unvalidly tender nice"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945733871095468272) 2025-07-17 06:34:39 UTC 1117 followers, 2926 engagements
"$IKNA closes. Rejoice for thy hard-earned stabledollars shalt be cast unto the fiery abyss. Not involved any more. Lets see if market buys the story but will probably stay very skeptical until there is placebo-controlled data as AD placebo response has been all over the place"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945218638027338165) 2025-07-15 20:27:18 UTC 1092 followers, 2026 engagements
"There was some interest on $BPMC thought Id write down. Didnt do a "KIT inhibitor" deep dive though scientific input welcome. link in bio / comment"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1943671058348880066) 2025-07-11 13:57:46 UTC 1117 followers, 2413 engagements
"Yeah maybe 8k will tell but ex-dates for CVRs in reverse mergers are pretty unpredictable sadly. It should be contingent on merger closing though so there should be time. Just tough to do in size if you dont like the stock. But NewCo should be down to single-digit EV so stock might even work at XX% of merger PIPE"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945223781775016395) 2025-07-15 20:47:44 UTC 1091 followers, XX engagements
"$PRTC No idea if there will be any consequences but nice to see that the Board is at least acknowledging shareholders frustration. Might we see. accountability Shocking possibility"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1934677213883826334) 2025-06-16 18:19:27 UTC 1117 followers, XXX engagements
"6) Company also owns some rights licensed to Eluminex. Company seems alive from what I can tell. $FGEN at least makes it looks somewhat important here:"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1943018193552834795) 2025-07-09 18:43:31 UTC 1117 followers, XXX engagements
"$FGEN behaving nicely. Still cheap at a fraction of net cash and below what the CEO payed after announcing AstraZeneca-transaction. Deal should close soon ("Q3") hoping for another bump in china net cash and therefore deal price"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945928254675636693) 2025-07-17 19:27:04 UTC 1117 followers, XXX engagements
"5) Further very decent Phase2-IPF-data as far as I can tell in May"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1945390262680744390) 2025-07-16 07:49:16 UTC 1109 followers, XXX engagements
"$VIGL traded decent chunk on X yday and today. This is up XXXX% in XX days on. absolutely nothing. Not exactly building generational wealth here but XX% annualized on a super boring arb Pricing in somewhere around X% PoS for the CVR at 7.99$ think that is a somewhat fairish area tbh (balancing historical fails of TREM2 vs Sanofi knowing maybe sometimes what they are doing)"
 [@AnotherBio](/creator/x/AnotherBio) on [X](/post/tweet/1942578371327598950) 2025-07-08 13:35:49 UTC 1114 followers, 1018 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@AnotherBio AnotherBioInvestor
AnotherBioInvestor posts on X about $prtc, $fgen, tang, $vigl the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX +572%
- X Month XXXXXX +14%
- X Months XXXXXX +3,284%
- X Year XXXXXX +288%
Mentions: XX #
Followers: XXXXX #
- X Week XXXXX +5.40%
- X Month XXXXX +18%
- X Months XXXXX +107%
- X Year XXXXX +124%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance stocks cryptocurrencies countries
Social topic influence $prtc #1, $fgen #1, tang, $vigl, $bpmc, decent, reverse, $bmy, holders, discount
Top assets mentioned Blueprint Medicines Corporation (BPMC) Bristol-Myers Squibb Co (BMY) Company (COMPANY) Sarepta Therapeutics, Inc. (SRPT) Synthetify (SNY) Sanofi (SNY)
Top Social Posts #
Top posts by engagements in the last XX hours
"1) Here is a thread about a takeover offer that was rebutted. AFAIK terms have never leaked. Thread includes a rough valuation but some pieces are a bit outdated ($BMY had a severe setback with Cobenfy for example but still a massive shot on goal this year)"
@AnotherBio on X 2025-07-16 07:49:14 UTC 1105 followers, XXX engagements
"Ladies and gents since it is officially shitco season time to check what we can still gobble up from the dumpsters. May I present: $FGEN In short: - Trades at XX% of net cash after asset sale to AstraZeneca closes - runway into H2 XX - Phase X mCRPC data of its ADC + PET Imaging Agent coming up in H2 XX - "maybe theres a chance" revival of Roxadustat in US in H2 2025 hopefully with a partner - Lo and behold - Insider Buys Stock has a horrible history with lead asset Roxadustat failing in US (approved and reasonably successful marketed in China with Astrazeneca). Why is the stock cheap and /" @AnotherBio on X 2025-07-09 18:43:28 UTC 1117 followers, 3553 engagements
"$CRGX Did not own this as discount to net cash was very small (as deal shows). Think it's a short above X as always dont trust Tang to monetize assets in best interest for CVR holders" @AnotherBio on X 2025-07-08 11:09:38 UTC 1117 followers, 1809 engagements
"$VIGL HSR expired. Will take profits for remaining position just keeping a tracker for the CVR. Returned XXX% or XX annualized from my write-up. CVR implies X% PoS at 8.08$ with zero closing risk assumed. Not a challenging valuation at all but probably justified given the minefield of Trem2-fails" @AnotherBio on X 2025-07-17 11:18:20 UTC 1117 followers, XXX engagements
"5) We have some pretty heavy catalysts in H2 2025 which can be pretty dramatic for a 25mln-US$-company. Please do not ask me on the science. It looks like a "might work"-thingy insiders are buying tons of cash lots of ways to wins - all I care about Another catalyst is of course closing the Astra sale and cash in amount of XXX times the market cap popping up on the balance sheet" @AnotherBio on X 2025-07-09 18:43:30 UTC 1117 followers, XXX engagements
"6) $VOR mooning hope $PRTC monetizes that stake valuation is incredibly high due to technical reasons (short interest low float newly issued shares not tradeable yet). Small impact (couple million $) but Ill take it" @AnotherBio on X 2025-07-16 07:49:17 UTC 1117 followers, XXX engagements
"$PRTC Made a post already yday on strong words of CEO / Chair in annual letter but have to follow up on this after reading the transcript. This is the most shareholder-friendly language I have seen in a long time in biotech (if not ever this is biotech though so bar is low 🙃) and coming from a highly credible company - one that already actually did a buyback and tender offer. The fact that you can buy this basically unchanged from this conference call is somewhat mindblowing to me" @AnotherBio on X 2025-05-01 07:55:50 UTC 1117 followers, 3959 engagements
"4) Results of AGM. Shareholders made their frustration noted Chair only received XX% of votes. Interestingly Ms Mazumdar-Shaw is somehow still on the board while CEO and BoD Chair have stepped down Not important but. the hell" @AnotherBio on X 2025-07-16 07:49:16 UTC 1107 followers, XXX engagements
"$PRTC looks like a ton is happening behind the scenes. BoD Chair and CEO have now been replaced. Both replacements are people with a very financy background which increases my conviction that $PRTC is in some stage of winddown or at least very severe consolidation. Have a lot of posts / threads all over the place will gather them right here. TLDR: Great r/r imo lots of ways to win lots of value people are saying all the right things. Now they need to walk the walk. Read the whole thing though you lazy asses" @AnotherBio on X 2025-07-16 07:49:14 UTC 1117 followers, 5318 engagements
"7) ex-CEO of $PRTC now CEO of $PRTC s largest holding (Seaport) making a bunch of interesting statements about creating shareholder value being very important and what M&A premium platform companies (like Seaport) are commanding. Exit / IPO coming" @AnotherBio on X 2025-07-16 07:49:18 UTC 1117 followers, XXX engagements
"$SRPT So they will probably do 1-2 bln in profits a year after everyone forgets about this and the stock sits at. 2.8bln $ Okay. (I know its more complicated than that but also.not really)" @AnotherBio on X 2025-07-16 20:15:14 UTC 1117 followers, 7485 engagements
"$IGMS Everybody: Well that IP is probably worth at least something or biobucks. Kevin Tang: Sorry bro zero is all I can do" @AnotherBio on X 2025-07-17 11:27:23 UTC 1117 followers, XXX engagements
"$BPMC lol I think thats a new one for me. You can unvalidly tender nice" @AnotherBio on X 2025-07-17 06:34:39 UTC 1117 followers, 2926 engagements
"$IKNA closes. Rejoice for thy hard-earned stabledollars shalt be cast unto the fiery abyss. Not involved any more. Lets see if market buys the story but will probably stay very skeptical until there is placebo-controlled data as AD placebo response has been all over the place" @AnotherBio on X 2025-07-15 20:27:18 UTC 1092 followers, 2026 engagements
"There was some interest on $BPMC thought Id write down. Didnt do a "KIT inhibitor" deep dive though scientific input welcome. link in bio / comment" @AnotherBio on X 2025-07-11 13:57:46 UTC 1117 followers, 2413 engagements
"Yeah maybe 8k will tell but ex-dates for CVRs in reverse mergers are pretty unpredictable sadly. It should be contingent on merger closing though so there should be time. Just tough to do in size if you dont like the stock. But NewCo should be down to single-digit EV so stock might even work at XX% of merger PIPE" @AnotherBio on X 2025-07-15 20:47:44 UTC 1091 followers, XX engagements
"$PRTC No idea if there will be any consequences but nice to see that the Board is at least acknowledging shareholders frustration. Might we see. accountability Shocking possibility" @AnotherBio on X 2025-06-16 18:19:27 UTC 1117 followers, XXX engagements
"6) Company also owns some rights licensed to Eluminex. Company seems alive from what I can tell. $FGEN at least makes it looks somewhat important here:" @AnotherBio on X 2025-07-09 18:43:31 UTC 1117 followers, XXX engagements
"$FGEN behaving nicely. Still cheap at a fraction of net cash and below what the CEO payed after announcing AstraZeneca-transaction. Deal should close soon ("Q3") hoping for another bump in china net cash and therefore deal price" @AnotherBio on X 2025-07-17 19:27:04 UTC 1117 followers, XXX engagements
"5) Further very decent Phase2-IPF-data as far as I can tell in May" @AnotherBio on X 2025-07-16 07:49:16 UTC 1109 followers, XXX engagements
"$VIGL traded decent chunk on X yday and today. This is up XXXX% in XX days on. absolutely nothing. Not exactly building generational wealth here but XX% annualized on a super boring arb Pricing in somewhere around X% PoS for the CVR at 7.99$ think that is a somewhat fairish area tbh (balancing historical fails of TREM2 vs Sanofi knowing maybe sometimes what they are doing)" @AnotherBio on X 2025-07-08 13:35:49 UTC 1114 followers, 1018 engagements